Participated · Series A · Oct 2025

Lula Commerce is a Philadelphia-based technology company that equips convenience retailers with an AI-powered platform to streamline digital commerce operations. Its suite includes Lula Hub, which consolidates third-party delivery marketplaces like Uber Eats, DoorDash, and Grubhub into a single dashboard; Lula Direct for branded web and mobile ordering; and Lula Operators, a collection of 30+ AI tools that automate refunds, reviews, uptime, and other critical tasks. The software also delivers inventory management, customer engagement, and business intelligence capabilities, helping stores improve efficiency and drive incremental sales. Lula has quickly scaled to serve industry leaders such as Circle K franchisees, United Pacific (Rocket/Alta Stores), Jacksons Food Stores, Par Mar Stores, Clipper Petroleum, and more than 50 regional chains, representing thousands of franchise locations across the United States. Management is actively hiring across engineering, sales, product, and customer success to support its growth. Including the newly announced round, the company has raised more than $16 million to date, which will fund product development and broader market expansion.

Participated · Series A · Oct 2025

Mondra provides an AI-powered supply chain intelligence platform that maps complex, farm-to-fork networks for the food industry using digital twin technology. The software delivers real-time data on carbon footprints, broader environmental impacts, price volatility and climate-related supply risks, integrating these insights into the existing systems of retailers, food producers and suppliers. Customers can generate audit-ready ESG data, analyse sourcing alternatives and collaborate with suppliers to prioritise emissions reductions while protecting profitability. Last year the company introduced Sherpa, an embedded AI assistant that acts as a co-pilot for decision-making across climate, social and financial dimensions. Mondra plans to extend its analytics beyond emissions tracking to cover supply-chain disruption and broader climate-risk management. Backed by new funding, the team will accelerate expansion into key European markets such as the Netherlands, Germany and France. Although specific revenue or user figures have not been disclosed, the firm positions itself as a critical enabler of Net Zero strategies within the global food sector.

Led · Seed · Jul 2024

Uncaged Innovations develops an animal-free leather alternative made from plant collagen using its proprietary BioFuze technology combined with roll-to-roll manufacturing. The company aims to mimic the texture and performance of traditional leather while reducing environmental impact: its product emits fewer greenhouse gases and uses less water and energy than conventional leather and is biodegradable. Uncaged focuses on scaling production to supply commercial customers and plans to support a commercial launch with the new funding. The company intends to expand its team, notably growing the manufacturing team to increase output. Founded by CEO Stephanie Downs and CTO Dr. Xiaokun Wang, Uncaged is positioning its solution as a sustainable replacement for animal leather. Uncaged Innovations develops a platform of biomimetic substitutes for animal hides, producing vegan leather alternatives that aim to match the luxury feel and durability of traditional leather. The company has built a formulation library based on composite plant-based proteins and polypeptides, leveraging grain proteins as the fundamental matrix to mimic the fibril structure of collagen. Its bioleather platform offers tunability to produce materials with varied mechanical and aesthetic properties for multiple end-use applications. Led by CEO Stephanie Downs, Uncaged positions its materials as sustainable replacements that mitigate environmentally harmful practices in the leather industry. The startup plans to use the recent funding to launch its vegan leather product. Financially, the company completed a $2M Pre-Seed raise.

Participated · Seed · Feb 2023

Future Fields’ core product is the EntoEngine, a platform that uses genetically engineered fruit flies grown in simple containers to produce human recombinant proteins as an alternative to traditional stainless‑steel bioreactors. The company positions this approach as more scalable, cost‑effective and sustainable, claiming EntoEngine can create biomass 16–30× faster and generate proteins daily with the same footprint. Its product suite includes five human recombinant proteins used in wound healing, reproductive biology, muscle and breast milk development, and stem cell research. Future Fields has shipped its animal protein product to more than 60 companies over the past 18 months and says its team has doubled in size during the last year. The company is building its first production facility next to its corporate headquarters in Edmonton, Canada, which it expects will enable kilogram‑scale recombinant protein production in roughly 10,000 square feet. The seed extension announced will fund that facility buildout and broader product launches into research, cell therapies and biopharmaceutical markets. Future Fields is a cellular agriculture company based in Edmonton, Alberta, Canada. It was co-founded by Matthew Anderson-Baron, Jalene Anderson-Baron and Lejjy Gafour. Future Fields develops a cellular growth medium that lowers the cost of producing lab-grown meat. The company participated in Y Combinator's S20 cohort. Future Fields raised $2.2M in seed financing led by Bee Partners. The company intends to use the funds to expand operations and business reach. Future Fields builds a cell growth medium intended to drive down the cost of cultured meat production. The founders — Matt and Jalene Anderson-Baron and Lejjy Gafour — pivoted from making lab-grown chicken to commercializing their growth serum after early experiments in Alberta. The company says it genetically modifies an organism to produce specific growth factors but does not disclose the exact cell line or technical details. Future Fields has paid contracts, is leaving the Y Combinator accelerator, and plans to roll out initial pilot product lines for shipment within the next month. It can currently produce a few hundred liters of growth factor and aims to scale to tens of thousands of liters per month over the next year, targeting production costs of about $2–$3 per liter at scale. The team positions the product as a key piece for the cellular agriculture industry to move from discovery to commercialization.

Participated · Seed · May 2022

Imagindairy is a Tel Aviv–based FoodTech startup that engineers animal-free dairy milk proteins via computational and molecular biology. Its technology enables production of a broad spectrum of dairy analogs, from raw milk to cheese, without involving animals. Imagindairy’s dairy proteins are described as non-GMO, cholesterol-free, and matching the flavor, texture, functionality, and nutritional value of cow-based counterparts. The company intends to use new funding to accelerate R&D and launch a range of real dairy products made without animals. It also plans to hire additional talent to support its expanding workforce. The company was co-founded by Tamir Tuller, PhD; Eyal Afergan, PhD; and Arie Abo, PhD. Imagindairy develops milk proteins identical to those from cows by feeding microorganisms rather than using cows, relying on a systems and synthetic biology platform. The company enables manufacturers to offer cow-free, sustainable milk and dairy products with the same nutritional values as dairy milk. It currently collaborates with dairy companies and offers a complete range of dairy-free proteins. Imagindairy plans to expand its facilities, increase its professional team, and boost R&D capacity. The company closed a $13M seed round to fund those initiatives. The business is led by co-founders Eyal Afergan, PhD (CEO) and Tamir Tuller, PhD (CSO), and is based in Tel Aviv, Israel. Imagindairy develops nature-identical, animal-free dairy proteins (whey and casein) using a microflora-based precision fermentation process. Its proteins are formulated to match the flavor, texture, functionality, and nutrient profile of cow’s milk, including calcium, while being lactose-free and free of cholesterol and GMOs. The technology is designed for ready integration into existing dairy food production facilities, enabling makers to produce dairy-analog products that closely mimic animal-derived versions. The company positions its approach as reducing the environmental burden of dairy livestock. Imagindairy has publicly raised US$1.5M in seed funding and says it will soon enter an A-round. Co-founder and CEO Eyal Afergan, PhD, is quoted outlining the company’s vision to deliver primary dairy proteins without animals.